언어 선택

Galectin-9

Galectin-9 분자 정보

영어 이름	Galactoside-binding lectin Galectin 9	시판 약물 수	0
임상 약물 수	2	표적 별명	Ecalectin，Tumor antigen HOM-HD-21，Galectin-9，Lectin， Galactoside-Binding， Soluble， 9，LGALS9
최고 연구 개발 단계	Phase 2 Clinical

영어 이름	Galactoside-binding lectin Galectin 9
표적 별명	Ecalectin，Tumor antigen HOM-HD-21，Galectin-9，Lectin， Galactoside-Binding， Soluble， 9，LGALS9
시판 약물 수	0
임상 약물 수	2
최고 연구 개발 단계	Phase 2 Clinical

Galectin-9 제품 목록

속성
Protein (3)
제품 라이브러리
온라인 (3)
종
Human (3)
태그
His Tag (1)His Tag & Avi Tag (1)Tag Free (1)
마커
Unconjugated (2)Biotin-labeled (1)

제품 번호	종	발현 시스템	제품 설명
LG9-H5213	Human	HEK293	Human Galectin-9 / LGALS9 Protein, Tag Free (MALS verified)
LG9-H5244	Human	HEK293	Human Galectin-9 / LGALS9 Protein, His Tag, low endotoxin
LG9-H82H3	Human	HEK293	Biotinylated Human Galectin-9 / LGALS9 Protein, His,Avitag™

총 수량3

Galectin-9분자 배경

Galectin-9 (LGALS9) is also known as tumor antigen HOM-HD-21 and ecalectin. Galectins are a family of proteins defined by their binding specificity for β-galactoside sugars, such as N-acetyllactosamine (Galβ1-3GlcNAc or Galβ1-4GlcNAc), which can be bound to proteins by either N-linked or O-linked glycosylation. As for Galectin-9, it has high affinity for the Forssman pentasaccharide, and it is also the ligand for HAVCR2/TIM3. Forthermore, Galectin-9 stimulates bactericidal activity in infected macrophages by causing macrophage activation and IL1B secretion which restricts intracellular bacterial growth.

Galectin-9분자 별명

Galectin-9,LGALS9,Ecalectin

임상 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	적응증	임상 시험
LYT-200	LYT-200	Phase 2 Clinical	Puretech Health	Carcinoma, Transitional Cell; Cholangiocarcinoma; Colorectal Neoplasms; Head and Neck Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasm Metastasis; Pancreatic Neoplasms; Solid tumours	상세
Anti-Gal9 antibody (Fibrogen)	FG-3165; HFB-200901; HFB-200902; HFB2009; HFB2009 series; HFB9-2	Phase 1 Clinical	HiFiBiO Therapeutics	Solid tumours	상세